Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Salon
Salon
Politics
Sarah K Burris

Trump can't quit hydroxychloroquine

LAS VEGAS, NV - SEPTEMBER 20: Fox News Channel and radio talk show host Sean Hannity (L) interviews U.S. President Donald Trump before a campaign rally at the Las Vegas Convention Center on September 20, 2018 in Las Vegas, Nevada. Photo by Ethan Miller/Getty Images

Former President Donald Trump joined Fox News host Sean Hannity Wednesday night to sing his own praises and declare that he was right about a litany of things.

His comments were similar to a news post that Trump's staff released on the website. One of those things he said he was 100 percent correct about was the power of hydroxychloroquine. Not only was he proven wrong about hydroxychloroquine, but some states that invested in the drug are also now losing money because they trusted Trump.

Oklahoma, for example, spent $2.6 million on the much-hyped drug to treat COVID-19. But when it came to May 2021, the state started scrambling to find places they could get rid of it before the drug expired.

"Oklahoma Attorney General Mike Hunter said Friday the state had reached an agreement with FFF Enterprises Inc. to take back the 1.2 million doses of hydroxychloroquine," reported Oklahoma Watch. "The agreement means the company won't face a lawsuit alleging the state overpaid for the drug, which is commonly used to treat lupus, rheumatoid arthritis and to prevent malaria. FFF denied overcharging the state."

"The state of Oklahoma is no longer interested in owning or possessing the products purchased from FFF Enterprises and has sought to return the products in exchange for a refund of total purchase price," the settlement agreement said, according to the report.

You can watch the video below via Twitter

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.